Table 2.

Observed 1-year rates and corresponding 95% CIs for all-cause mortality, non-haemorrhagic stroke/SE and major bleeding by region and in all 35 countries in GARFIELD-AF

Region	Outcome
	Mortality	Non-haemorrhagic stroke/SE	Major bleeding
Europe	4.4 (4.2 to 4.6)	1.2 (1.1 to 1.3)	1.3 (1.2 to 1.4)
Asia	2.8 (2.6 to 3.1)	1.0 (0.9 to 1.2)	0.9 (0.7 to 1.0)
Latin America	5.5 (4.8 to 6.2)	1.4 (1.1 to 1.8)	1.3 (1.0 to 1.7)
North America	5.9 (4.8 to 7.2)	1.0 (0.6 to 1.6)	2.9 (2.2 to 3.8)
Other countries	6.0 (5.1 to 7.0)	1.8 (1.3 to 2.4)	1.3 (0.9 to 1.9)
All countries	4.2 (4.0 to 4.4)	1.2 (1.1 to 1.3)	1.2 (1.1 to 1.3)

GARFIELD-AF, Global Anticoagulant Registry in the FIELD-Atrial Fibrillation; SE, systemic embolism.